Ivor S Douglas Selected Research

Ivor S Douglas Research Topics

Disease

12	Sepsis (Septicemia) 01/2022 - 11/2008
10	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 10/2009
7	Infections 05/2022 - 02/2013
7	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2011
7	Septic Shock (Toxic Shock Syndrome) 10/2020 - 11/2008
7	Critical Illness (Critically Ill) 01/2020 - 03/2014
7	Inflammation (Inflammations) 01/2018 - 05/2005
7	Lung Injury 11/2016 - 03/2006
5	Shock 01/2020 - 09/2011
4	COVID-19 05/2022 - 01/2021
4	Pneumonia (Pneumonitis) 05/2022 - 04/2016
4	Chronic Obstructive Pulmonary Disease (COPD) 11/2017 - 11/2006
4	Acute Kidney Injury (Acute Renal Failure) 06/2014 - 01/2007
3	Acute Lung Injury 09/2011 - 03/2006
2	Edema (Dropsy) 01/2021 - 10/2018
2	Heart Failure 01/2018 - 11/2017
2	Necrosis 06/2014 - 03/2006
2	Ulcer 02/2013 - 02/2013
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2013 - 02/2013
2	Hypoxia (Hypoxemia) 02/2013 - 02/2013
2	Hypovolemia 02/2013 - 02/2013
2	Low Cardiac Output 02/2013 - 02/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 02/2013 - 02/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2013 - 02/2013
2	Death (Near-Death Experience) 02/2013 - 02/2013
2	Hemorrhage 02/2013 - 02/2013
2	Pulmonary Edema 09/2011 - 10/2008
1	Severe Acute Respiratory Syndrome 05/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Heart Arrest (Cardiac Arrest) 10/2021
1	Body Weight (Weight, Body) 01/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2020
1	Dyspnea (Shortness of Breath) 11/2020
1	Cicatrix (Scar) 11/2020
1	Diabetes Insipidus 01/2020
1	Coma (Comas) 12/2018
1	Confusion (Bewilderment) 12/2018
1	Delirium 12/2018

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 02/2013
5	Proteins (Proteins, Gene)FDA Link 11/2016 - 03/2006
4	Vasopressins (Vasopressin)IBA 10/2021 - 02/2013
4	Oxygen (Dioxygen)IBA 11/2020 - 02/2013
4	Biomarkers (Surrogate Marker)IBA 09/2014 - 06/2006
3	CytokinesIBA 01/2017 - 01/2007
3	GlycosaminoglycansIBA 01/2016 - 03/2014
3	AlbuminsIBA 10/2015 - 02/2013
3	Crystalloid SolutionsIBA 10/2015 - 02/2013
3	ChemokinesIBA 10/2008 - 05/2005
2	tocilizumab (atlizumab)FDA Link 05/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2021 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2008
2	EphA2 ReceptorIBA 01/2018 - 11/2016
2	LipopolysaccharidesIBA 11/2016 - 08/2007
2	Cadherins (E-Cadherin)IBA 11/2016 - 03/2006
2	DisaccharidesIBA 06/2015 - 03/2014
2	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 01/2007
2	CreatinineIBA 06/2014 - 12/2011
2	Heparitin Sulfate (Heparan Sulfate)IBA 03/2014 - 08/2012
2	Lipid AIBA 01/2014 - 08/2007
2	Vasodilator Agents (Vasodilators)IBA 02/2013 - 02/2013
2	Blood Glucose (Blood Sugar)IBA 02/2013 - 02/2013
2	Dobutamine FDA LinkGeneric 02/2013 - 02/2013
2	Dopamine (Intropin)FDA LinkGeneric 02/2013 - 02/2013
2	Epinephrine (Adrenaline)FDA LinkGeneric 02/2013 - 02/2013
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 02/2013
2	Hemoglobins (Hemoglobin)IBA 02/2013 - 02/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2013 - 02/2013
2	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 02/2013 - 02/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2013 - 02/2013
2	Insulin (Novolin)FDA Link 02/2013 - 02/2013
2	Neuromuscular Blocking AgentsIBA 02/2013 - 02/2013
2	drotrecogin alfa activated (Xigris)FDA Link 05/2012 - 11/2008
2	Protein CIBA 05/2012 - 11/2008
2	Peroxidase (Myeloperoxidase)IBA 10/2008 - 01/2007
2	IntegrinsIBA 09/2007 - 03/2006
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	SteroidsIBA 10/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2018
1	Antipsychotic Agents (Antipsychotics)IBA 12/2018
1	ziprasidone (Geodon)FDA Link 12/2018
1	Haloperidol (Haldol)FDA LinkGeneric 12/2018

Therapy/Procedure

8	Therapeutics 01/2020 - 05/2005
7	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2009
6	Resuscitation 01/2022 - 02/2013
5	Critical Care (Surgical Intensive Care) 01/2020 - 01/2007
3	Noninvasive Ventilation 11/2017 - 10/2016
2	Resuscitation Orders (Do Not Resuscitate Orders) 01/2022 - 01/2017
2	Length of Stay 01/2021 - 12/2020
2	Patient Readmission 01/2017 - 09/2013
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 02/2013 - 02/2013
2	Cannula 02/2013 - 02/2013
2	Continuous Renal Replacement Therapy 02/2013 - 02/2013
2	Renal Dialysis (Hemodialysis) 02/2013 - 02/2013
2	Mechanical Ventilators (Ventilator) 09/2011 - 10/2009
2	Nephrectomy 10/2008 - 01/2007
1	Intravenous Infusions 01/2021
1	Personal Protective Equipment 01/2021
1	Tracheostomy 11/2019